All Stories

  1. Population heterogeneity in Cryptococcus neoformans: Impact on pathogenesis
  2. Emerging mould infections: Get prepared to meet unexpected fungi in your patient
  3. Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination
  4. Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype
  5. Intranasal inoculation of Cryptococcus neoformans in mice produces nasal infection with rapid brain dissemination
  6. The enigmatic role of fungal annexins: the case of Cryptococcus neoformans
  7. Recent advances in managing HIV-associated cryptococcal meningitis
  8. The enigmatic role of fungal annexins: the case of Cryptococcus neoformans
  9. Recent advances in the understanding and management of mucormycosis
  10. Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together
  11. Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study
  12. Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us?
  13. Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?
  14. Diagnosis of invasive aspergillosis
  15. Faculty of 1000 evaluation for Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
  16. Performance evaluation of multiplex PCR including Aspergillus—not so simple!: Table 1.
  17. Copy Number Variation of Mitochondrial DNA Genes in Pneumocystis jirovecii According to the Fungal Load in BAL Specimens
  18. Detection of circulating Mucorales DNA in critically ill burn patients: preliminary report of a screening strategy for early diagnosis and treatment
  19. Seroprevalence of Toxoplasma gondii and direct genotyping using minisequencing in free-range pigs in Burkina Faso
  20. Les infections fongiques nasosinusiennes ne sont pas uniquement liées aux mucorales et aux Aspergillus !
  21. Variation in copy number of the 28S rDNA of Aspergillus fumigatus measured by droplet digital PCR and analog quantitative real-time PCR
  22. New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?: Table 1.
  23. Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing
  24. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
  25. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients
  26. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
  27. Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis
  28. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
  29. Des cryptocoques où on ne les attend pas : à propos de cinq cas extracérébraux et extrapulmonaires
  30. Mucormycosis: New Developments into a Persistently Devastating Infection
  31. Immunodépression des brûlés graves et infections fongiques invasives : un rôle des cellules myéloïdes suppressives
  32. La détection de l’ADN mucoral circulant permet d’anticiper le diagnostic de mucormycose invasive chez les patients brûlés graves
  33. Short tandem repeat genotyping for P. jirovecii is more sensitive to mixed genotype than MLST
  34. Adaptation de Cryptococcus neoformans à l’hôte, vers la mise en évidence de la dormance d’un point de vue biologique
  35. Épidémie de mucormycose dans un centre de traitement des brûlés : des biomarqueurs diagnostiques au séquençage complets des souches
  36. High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?
  37. Performance d’une puce à ADN pan-fongique pour le diagnostic étiologique des infections fongiques, à partir de prélèvements profonds
  38. Correlation BetweenPneumocystis jiroveciiMitochondrial Genotypes and High and Low Fungal Loads Assessed by Single Nucleotide Primer Extension Assay and Quantitative Real-Time PCR
  39. Agents of Systemic and Subcutaneous Mucormycosis and Entomophthoromycosis
  40. New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards
  41. Dual Invasive Infection with Phaeoacremonium parasiticum and Paraconiothyrium cyclothyrioides in a Renal Transplant Recipient: Case Report and Comprehensive Review of the Literature of Phaeoacremonium Phaeohyphomycosis
  42. Importance of Operational Factors in the Reproducibility of Aspergillus Galactomannan Enzyme Immune Assay
  43. Cryptococcus neoformans Host Adaptation: Toward Biological Evidence of Dormancy
  44. Muscle diffusion of liposomal amphotericin B and posaconazole in critically ill burn patients receiving continuous hemodialysis
  45. Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection withHormographiella aspergillatain an acute leukaemia patient
  46. Aspergilloses pulmonaires invasives survenant sous traitement par posaconazole (PZA)
  47. Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia
  48. Mucormycosis
  49. Des cryptocoques où on ne les attend pas : à propos de cinq cas extra-cérébraux et extra-pulmonaires
  50. Données cliniques, histopathologiques et moléculaires d’une série de mucormycoses
  51. Nouvelle méthode de typage moléculaire de Pneumocystis jirovecii par analyse de marqueurs microsatellites
  52. Diagnosis of Pneumocystis jirovecii Pneumonia: Role of β-D-Glucan Detection and PCR
  53. Antifungal pre-emptive strategy for high-risk neutropenic patients: why the story is still ongoing
  54. Difficulties with molecular diagnostic tests for mould and yeast infections: where do we stand?
  55. Iterative breakthrough invasive aspergillosis due to TR(34)/L98H azole-resistantAspergillus fumigatusandEmericella sublatain a single hematopoietic stem cell transplant patient
  56. Misidentification of Saprochaete clavata as Magnusiomyces capitatus in Clinical Isolates: Utility of Internal Transcribed Spacer Sequencing and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Importance of Reliable Data...
  57. Épidémiologie de la résistance des champignons : impact de nos prescriptions d’antifongiques
  58. Recherche
  59. A. fumigatus et azoles : inadequation des breackpoints eucast pour l’interpretation des Etests
  60. Le milieu au malt en primoculture améliore et accélère l’identification des moisissures
  61. Une PCR quantitative positive a Pneumocystis jirovecii dans une aspiration naso-pharyngée est évocatrice d’une pneumocystose pulmonaire chez des patients avec atteinte pulmonaire fébrile
  62. Faculty Opinions recommendation of Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans.
  63. Direct genotyping of Toxoplasma gondii from amniotic fluids based on B1 gene polymorphism using minisequencing analysis
  64. Faculty Opinions recommendation of The transcriptional response of Cryptococcus neoformans to ingestion by Acanthamoeba castellanii and macrophages provides insights into the evolutionary adaptation to the mammalian host.
  65. Faculty Opinions recommendation of De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient.
  66. La spectrométrie de masse de type MALDI-TOF en mycologie clinique : avantages réels, écueils potentiels
  67. Faculty Opinions recommendation of Real-time in vivo imaging of fungal migration to the central nervous system.
  68. Faculty Opinions recommendation of Fungi and the rise of mammals.
  69. Azole Preexposure Affects the Aspergillus fumigatus Population in Patients
  70. Faculty Opinions recommendation of The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
  71. In VitroCombination of Anidulafungin and Voriconazole against Intrinsically Azole-Susceptible and -Resistant Aspergillus spp.
  72. Faculty Opinions recommendation of A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence.
  73. Faculty Opinions recommendation of Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.
  74. Faculty Opinions recommendation of Identification and characterization of an Aspergillus fumigatus "supermater" pair.
  75. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients
  76. Dynamics of Cryptococcus neoformans-Macrophage Interactions Reveal that Fungal Background Influences Outcome during Cryptococcal Meningoencephalitis in Humans
  77. Azole Resistance in Aspergillus fumigatus—Current Epidemiology and Future Perspectives
  78. Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species
  79. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies--authors' response
  80. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies
  81. Microsporum praecox: Molecular Identification of a New Case and Review of the Literature
  82. Résistance microbiologique des Aspergillus aux antifongiques : de l’identification au séquençage des mutations
  83. Real-Time Identification of Bacteria and Candida Species in Positive Blood Culture Broths by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
  84. Aspergilloses et Aspergillus : résistance clinique et microbiologique aux antifongiques
  85. MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole
  86. SUPERFICIAL BLADDER UROTHELILAL CELL CARCINOMA PROGNOSTIC FACTORS : PROSPECTIVE EVALUATION OF COMBINED FGFR3/P53 GENOTYPES
  87. Invasive Pulmonary Infection Due toTrichoderma longibrachiatumMimicking Invasive Aspergillosis in a Neutropenic Patient Successfully Treated with Voriconazole Combined with Caspofungin
  88. 498 SUPERFICIAL BLADDER UROTHELIAL CELL CARCINOMA PROGNOSTIC FACTORS: PROSPECTIVE EVALUATION OF COMBINED FGFR3/P53 GENOTYPES
  89. Faculty of 1000 evaluation for Are Human Intestinal Eukaryotes Beneficial or Commensals?
  90. Faculty of 1000 evaluation for Intracellular Action of a Secreted Peptide Required for Fungal Virulence.
  91. Faculty of 1000 evaluation for Protein Composition of Infectious Spores Reveals Novel Sexual Development and Germination Factors in Cryptococcus.